Bibliografische Daten

Dokument US000011179337B2 (Seiten: 45)

Bibliografische Daten Dokument US000011179337B2 (Seiten: 45)
INID Kriterium Feld Inhalt
54 Titel TI [EN] Dry powder composition comprising long-chain RNA
71/73 Anmelder/Inhaber PA CUREVAC AG, DE
72 Erfinder IN EBER FABIAN JOHANNES, DE ; KETTERER THOMAS, DE ; KOLLAND KATHARINA, DE ; MUTZKE THORSTEN, DE ; ROOS TILMANN, DE ; SEWING STEFANIE, DE ; SONNTAG MICHAEL, DE ; WIGGENHORN MICHAEL, DE ; YAZDAN PANAH BENYAMIN, DE
22/96 Anmeldedatum AD 11.11.2019
21 Anmeldenummer AN 201916679536
Anmeldeland AC US
Veröffentlichungsdatum PUB 23.11.2021
33
31
32
Priorität PRC
PRN
PRD
EP
2015002019
13.10.2015
33
31
32
PRC
PRN
PRD
EP
2016000842
20.05.2016
33
31
32
PRC
PRN
PRD
EP
15001517
20.05.2015
33
31
32
PRC
PRN
PRD
US
201715575284
17.11.2017
51 IPC-Hauptklasse ICM A61K 48/00 (2006.01)
51 IPC-Nebenklasse ICS A61K 39/145 (2006.01)
A61K 9/16 (2006.01)
A61P 31/00 (2006.01)
A61P 31/04 (2006.01)
A61P 31/12 (2006.01)
A61P 33/02 (2006.01)
A61P 35/00 (2006.01)
A61P 37/06 (2006.01)
A61P 37/08 (2006.01)
IPC-Zusatzklasse ICA A61K 39/00 (2006.01)
IPC-Indexklasse ICI
Gemeinsame Patentklassifikation CPC A61K 2039/53
A61K 39/145
A61K 48/00
A61K 48/005
A61K 48/0091
A61K 9/16
A61K 9/1682
A61P 31/00
A61P 31/04
A61P 31/12
A61P 33/02
A61P 35/00
A61P 37/06
A61P 37/08
MCD-Hauptklasse MCM A61K 48/00 (2006.01)
MCD-Nebenklasse MCS A61K 39/145 (2006.01)
A61K 9/16 (2006.01)
A61P 31/00 (2006.01)
A61P 31/04 (2006.01)
A61P 31/12 (2006.01)
A61P 33/02 (2006.01)
A61P 35/00 (2006.01)
A61P 37/06 (2006.01)
A61P 37/08 (2006.01)
MCD-Zusatzklasse MCA A61K 39/00 (2006.01)
57 Zusammenfassung AB [EN] The present invention is directed to a storage-stable formulation of long-chain RNA. In particular, the invention concerns a dry powder composition comprising a long-chain RNA molecule. The present invention is furthermore directed to methods for preparing a dry powder composition comprising a long-chain RNA molecule by spray-drying. The invention further concerns the use of such a dry powder composition comprising a long-chain RNA molecule in the preparation of pharmaceutical compositions and vaccines, to a method of treating or preventing a disorder or a disease, to first and second medical uses of such a dry powder composition comprising a long-chain RNA molecule and to kits, particularly to kits of parts, comprising such a dry powder composition comprising a long-chain RNA molecule.
56 Entgegengehaltene Patentdokumente/Zitate,
in Recherche ermittelt
CT
56 Entgegengehaltene Patentdokumente/Zitate,
vom Anmelder genannt
CT US020020150626A1
US020050032730A1
US020050059624A1
US020050250723A1
US020060188490A1
US020070172430A1
US020080025944A1
US020080267873A1
US020090324584A1
US020100048883A1
US020100189729A1
US020100203076A1
US020100291156A1
US020100305196A1
US020110053829A1
US020110250225A1
US020120021043A1
US020120258046A1
US020130129754A1
US020130142818A1
US020130259879A1
US020130280283A1
US020130295043A1
US020130336998A1
US020150037326A1
US020150050302A1
US020150057340A1
US020150093413A1
US020150118183A1
US020150118264A1
US020150165006A1
US020150184195A1
US020150218554A1
US020150306249A1
US020150320847A1
US020160130345A1
US020160166668A1
US020160166678A1
US020160166710A1
US020160166711A1
US020160168207A1
US020160168227A1
US020160235864A1
US020160304883A1
US020160304938A1
US020160326575A1
US020160331844A1
US020170014496A1
US020170029847A1
US020170114378A1
US020170252430A1
US020170304459A1
US020170326225A1
US020180044687A1
US020180125952A1
US020180126003A1
US020180142275A1
US020180147146A1
US020180148727A1
WO002011069528A1
WO002011069529A1
WO002016165825A1
WO002016165831A1
WO002016174227A1
WO002016184576A2
WO002016193206A1
WO002016193226A1
WO002016203025A1
WO002017001058A1
WO002017009376A1
WO002017021546A1
WO002017025120A1
WO002017025447A1
WO002017036580A1
WO002017064146A1
WO002017081110A1
WO002017108087A1
WO002017109134A1
WO002017109161A1
WO002020023533A1
56 Entgegengehaltene Nichtpatentliteratur/Zitate,
in Recherche ermittelt
CTNP
56 Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt
CTNP “Mini-Buchi Spray Dryer,” technical specification sheet downloaded from Buchi.com on May 20, 2019. 1;
International Preliminary Report Patentability issued in corresponding PCT Application No. PCT/EP2016/000843, dated Nov. 15, 2016. 1;
International Search Report and Written Opinion issued in corresponding PCT Application No. PCT/EP2016/000843, dated Nov. 15, 2016. 1;
Jensen et al., “Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation,” J. Control. Release, 142(1):138-145, 2010. 1;
Office Action issued in U.S. Appl. No. 15/575,284, dated Aug. 28, 2018. 1;
Office Action issued in U.S. Appl. No. 15/575,284, dated May 23, 2019. 1;
Office Action issued in U.S. Appl. No. 15/575,284, dated Nov. 16, 2018. 1;
Qiu et al., “Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide,” Journal of Controlled Release, 314:102-115, 2019. 1
Zitierende Dokumente Dokumente ermitteln
Sequenzprotokoll
Prüfstoff-IPC ICP A61K 48/00
A61K 9/16
A61P 31/00
A61P 31/04
A61P 31/12
A61P 33/02
A61P 35/00
A61P 37/06
A61P 37/08